Mike Biotech announced on January 7 that the company's cross-matching blood quality control products obtained a medical device registration certificate issued by the State Drug Administration. This product is used in conjunction with the anti-human globulin test card produced by our company. It is used for quality control of manual and fully automatic blood type analysis system cross-matching tests. It is only used for clinical testing, not for blood source screening. Obtaining a registration certificate for the new product further enriches the company's product project menu, helps enhance the company's overall market competitiveness, and will have a positive impact on market expansion and the company's future operations. The actual sales situation of the product covered by the above registration certificate depends on future marketing results, and it is currently impossible to predict the impact of this product on the company's future revenue.

Mike Biotech announced on January 7 that the company's cross-matching blood quality control products obtained a medical device registration certificate issued by the State Drug Administration. This product is used in conjunction with the anti-human globulin test card produced by our company. It is used for quality control of manual and fully automatic blood type analysis system cross-matching tests. It is only used for clinical testing, not for blood source screening. Obtaining a registration certificate for the new product further enriches the company's product project menu, helps enhance the company's overall market competitiveness, and will have a positive impact on market expansion and the company's future operations. The actual sales situation of the product covered by the above registration certificate depends on future marketing results, and it is currently impossible to predict the impact of this product on the company's future revenue.